Bio/Health Sciences

ATI’s Bio/Health Sciences program focuses on human health – medical devices, diagnostics, research tools, and therapeutics. Our team has deep expertise in the regulatory pathways and reimbursement landscapes that these startups have to navigate.


Admittance Technologies

Algorithms and associated hardware that enhance the performance of existing cardiac devices (e.g., heart failure diagnosis, pacemaker ‘tuning’).


Aeglea BioTherapeutics

Aeglea BioTherapeutics is developing novel engineered human enzyme drug candidates that selectively target and inactivate amino acids required in tumorigenesis.

health science

Alafair Biosciences

Advanced post-surgical adhesion barrier. First application: tendon repair.

curtana pharma logo

Curtana Pharmaceuticals

Preclinical-stage biopharmaceutical company developing small molecule therapeutics for cancer stem cells in the central nervous system for the treatment of glioblastoma multiforme (GBM) and other brain cancers.

health science

Lumos Pharmaceuticals

Lumos Pharma is a biotechnology company dedicated to developing a treatment for Creatine Transporter Deficiency (CTD) patients and their families.


Lung Therapeutics

Developing treatments for niche, orphan drug indications for which there is no effective therapeutic option. First application: pleural disease.


Siva Therapeutics

Nanotechnology therapies that improve cancer treatment options for patients and physicians.